Five MSOs Report $2B in Uncertain Tax Liabilities as IRS Waits
Disclosures from five major cannabis companies put roughly $2 billion in unresolved tax exposure on the books while IRS guidance on 280E remains pending, according to The Marijuana Herald.

Top view of tax documents, calculator, magnifying glass, and calendar on a black surface.
Five operators, one unresolved tax question
The Marijuana Herald reported on Nov. 14 that five major marijuana companies disclose roughly $2 billion in uncertain tax liabilities while IRS guidance remains pending.
That report did not break out the figure by company in the material reviewed for this story, and CannIntel has not independently verified the individual filings. The aggregate is large enough on its own. It sits on the books as a reserve, not a payment, which is what makes it so awkward.
Why the liabilities exist
Uncertain tax positions arise because 280E bars plant-touching cannabis businesses from deducting ordinary expenses, while operators' own filing positions may diverge from what the IRS would accept.
Under Section 280E of the tax code, companies trafficking in Schedule I or II substances can't deduct most operating costs beyond cost of goods sold. Many multistate operators have taken filing positions that assume friendlier treatment, and accounting rules force them to reserve against the chance those positions get rejected.
That's the mechanism. The IRS hasn't told anyone which side of the line they're on.
What pending guidance does to a balance sheet
Without IRS direction, companies can't release reserves, can't price tax into forward guidance, and can't cleanly model free cash flow.
For finance teams, an open-ended reserve drags on every downstream decision. Lenders look at it when sizing credit facilities, acquirers look at it when pricing deals, and investors discount it when comparing cash generation against peers.
A $2 billion reserve is a bet on timing as much as on law: the money stays frozen until the IRS says something, and no one outside the agency knows when that will be.
The operational layer: tax data is now a systems problem
Uncertain-position reserves put pressure on the seed-to-sale and POS data feeding tax workpapers, because defensible cost-of-goods allocation depends on clean inventory and transaction records.
Under 280E, every dollar that can be properly classified as cost of goods sold is a dollar that stays deductible. Inventory costing is a direct tax lever, and so is the data flowing from track-and-trace systems such as METRC and BioTrack into accounting platforms. Operators with sloppy integrations between POS, seed-to-sale and the general ledger are the ones least able to defend their positions in an audit.
Expect finance and compliance budgets to tilt toward tooling that ties inventory movement to ledger entries. Vendors selling that integration have a clearer pitch than they did a year ago.
What to watch
The IRS timeline is the only variable that matters here. Watch the next round of quarterly filings for any reserve releases or increases, and for shifts in the language of tax footnotes. For full background, see the CannIntel topic hub on 280E tax burden and IRS guidance.
For complete background, history, and our ongoing coverage of this story:
Open the CannIntel topic hub →Frequently asked questions
What are uncertain tax liabilities for cannabis companies?
They're reserves a company books against tax positions the IRS might reject. For cannabis operators, many stem from 280E, which limits deductions, and from filing positions that may differ from what the IRS would accept.
How large are the liabilities reported?
The Marijuana Herald reported that five major marijuana companies disclose a combined total of roughly $2 billion in uncertain tax liabilities.
What is Section 280E?
Section 280E of the federal tax code bars businesses trafficking in Schedule I or II controlled substances from deducting most ordinary business expenses, leaving cost of goods sold as the main allowable deduction.
Why does pending IRS guidance matter?
Until the IRS clarifies its position, operators can't resolve their reserves, which affects financial reporting, debt capacity, deal valuation and cash-flow forecasting.
Sources
The cannabis newsletter you forward to your team.
Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.
No spam. Unsubscribe with one click. 21+ only.
Related from Business

Village Farms Earnings Call Signals Growth Ahead, TipRanks Reports
A TipRanks summary of Village Farms International's latest earnings call points to a growth outlook, but the detail investors need sits in the company's own filings.

IM Cannabis reports C$1.65M revenue after European sale
The Israel-linked operator's reported revenue base shrank to C$1.65 million as the sale of its European business reshaped what the company actually reports.

Organigram gets Nasdaq bid-price notice, May 2027 deadline
Nasdaq flagged the Canadian licensed producer for a sub-$1 share price, starting a compliance clock that runs to May 2027.
More from the newsroom

Washington Seeks Second Delay in Supreme Court Cannabis Residency Case
Challengers oppose a second postponement request in the high court case over state residency rules for marijuana licenses, a dispute that touches the dormant Commerce Clause.

Joe Rogan Says Weed Was a Big Reason Texas Turned Blue
The podcaster's argument, reported by Mediaite on Nov. 14, 2026, puts Texas cannabis policy and a young male voting bloc at the center of a political fight.

New York Cannabis Taxes Hit $173.4M in 2025, Report Shows
New York's adult-use market paid $173,363,400 in cannabis taxes in 2025, according to a stupidDOPE report, a first full-year benchmark for the state's slow-rolling rollout.